Profile
Corporate information
Official name
Callisto Pharmaceuticals Inc
Registration country
Official name
Callisto Pharmaceuticals Inc
Registration country
Investment activity status
Active investor
Company type
Public biotechnology company that develops novel therapeutics to treat cancer.Funding
Funding rounds
Investor | Profile | Country | Notes | |
---|---|---|---|---|
Alta Partners LP | Venture capital firm based in San Francisco which invests primarily in biotechnology and life science companies. | United States | ||
Balyasny Asset Management LP | ||||
Credit Suisse Group AG | Switzerland | |||
New England Partners Capital LP | United States | |||
Paramount Capital |
Cap Table
Current and past shareholders
Investor | Contacts | Round | |
---|---|---|---|
Alta Partners LP Venture capital firm based in San Francisco which invests primarily in biotechnology and life science companies. |
+1 (415) 362-4022 |
N/A | |
Balyasny Asset Management LP |
N/A | ||
Credit Suisse Group AG |
N/A | ||
New England Partners Capital LP |
+1 (617) 472-2805 |
N/A | |
Paramount Capital |
N/A |